Surgeons can refine their workflow, partner with an optometrist.
Paul Badawi, co-founder and CEO of Sight Sciences, sits down with host Neda Shamie, MD, to discuss his journey into the field of eye care, what motivates him, the transformative approach to glaucoma patient care, and the spark that led him and his ophthalmologist brother, David Badawi, MD, to start the company together.
Although minimally invasive procedure gives hope, additional research is required.
Adolf Fercher's 2D image of fundus paved way for today’s imaging technique.
According to Thomas Aaberg, MR, the novel therapy is geared to treat rare, debilitating eye disease.
Research can drive opportunities for patients with rare diseases
A powerful conversation about expectations can open communication and trust.
Daniel F Kiernan, MD, FACS, discusses the use of anti-inflammatory treatment when experiencing sub-optimal response with anti-VEGF therapy in DME.
The method by which sedation is applied to keep patients relaxed and comfortable throughout cataract surgery can be tailored similar to that of anesthesia — surgical anesthesia is not a one size fits all endeavor.
New acrylic implant provides option for patients with endothelial dysfunction.
Presbyopia-correcting drops represent a whole new product category—one with a lot of upsides for clinicians who want to help their patients see well at all distances.
Studies on nurse-led services find a low level of complications among patients.
Short learning curve, significant clinical advantages make this a comfortable addition.
During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
Contemporary scleral lenses work so well that stable vision in them cannot necessarily be taken as a sign that KC progression has stopped. Determination of KC progression requires advanced imaging.
Delivered in a water-free solution, Vevye’s new formulation offers a high concentration of cyclosporine that works rapidly, has no preservatives, and rarely causes irritation
Sometimes, the best job for you is the one you create.
NCP should be considered for patients with discomfort, irritation, dryness, grittiness.
David A. Eichenbaum, MD, FASRS and Caroline Baumal, MD provide take-home messages to providers treating AMD and DME.
Retina experts deliberate on the role of fluorescein angiography in AMD and discuss initiation of anticomplement therapy for geographic atrophy in conjunction with anti-VEGF therapy for neovascular AMD.
Noncontact esthesiometry screens for all levels of neurotrophic keratitis.
Spaceflight-associated neuro-ocular syndrome a potential challenge during long missions.
Long-term screen users and contact lens wearers in group face challenges.
Retina experts deliberate on the role of fluorescein angiography in AMD and discuss initiation of anticomplement therapy for geographic atrophy in conjunction with anti-VEGF therapy for neovascular AMD.